Loading
Life sciences · Review
Cell Proliferation · November 4, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Review.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
In 2017, lactate was proposed not only as an anaerobic glycolytic metabolite but also as a carbon source involved in the mitochondrial tricarboxylic acid cycle. Lactate plays various biological regulatory roles, such as in energy sources, signalling molecules, and immunomodulatory molecules. Increasing evidence has shown that lactate accumulation in the tumour microenvironment is a hallmark of cancer. However, the mechanisms underlying the role of lactate in cancer progression remain unclear. Recently, various metabolites, including lactate, were shown to regulate epigenetic modifications in a concentration-dependent manner. In this review, we discuss advancements in the field that show how lactate and lactylation can accelerate the progression of cancer. The synthesis of the studies discussed herein may serve as a theoretical foundation for identifying novel mechanisms underlying rapid tumour progression and provide further insights that will benefit cancer therapies.